{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:59:25Z","timestamp":1790762365798,"version":"4.1.0"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["Nos.82327803"],"award-info":[{"award-number":["Nos.82327803"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["Nos.82441014"],"award-info":[{"award-number":["Nos.82441014"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["Nos. 82302146"],"award-info":[{"award-number":["Nos. 82302146"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Insights Imaging"],"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Parkinson\u2019s disease (PD), the second most common neurodegenerative disorder, poses a significant challenge to elderly health. Its diagnosis currently relies primarily on clinical symptoms, which often proves inadequate for differentiating PD from other forms of parkinsonism, particularly in early disease stages. Although positron emission tomography (PET) has offered compelling evidence supporting the differential diagnosis of PD, its high cost and radiation exposure limit its widespread use. Consequently, there is a pressing need for more accessible, convenient, non-invasive, and safe diagnostic approaches. The \u201cswallow tail sign\u201d (STS)\u2014an MRI-based biomarker characterized by a hyperintensity in the posterolateral substantia nigra pars compacta (SNc), surrounded by hypointense areas\u2014has emerged as a highly promising adjunct tool. This biomarker holds potential not only to enhance diagnostic certainty in distinguishing PD from similar neurodegenerative disorders but also to improve the understanding of its pathophysiology. In this review, we outline the anatomical basis of the STS and the pathological changes in PD leading to its disappearance. We further summarize its applications across various magnetic resonance imaging (MRI) techniques and evaluate its value in identifying PD and differentiating it from other parkinsonian syndromes. With significant advancements in ultra-high-field MRI (\u2265\u20097\u2009T) and artificial intelligence (AI), combined with other MRI biomarkers, the value of STS will be further explored in the future.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:bold>Question<\/jats:bold>\n                      Despite its diagnostic potential, the biological basis, imaging interpretation, and clinical utility of the STS remain incompletely understood and warrant further investigation in parkinsonism.\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:bold>Findings<\/jats:bold>\n                      The normal STS appears as dorsolateral nigral hyperintensity on susceptibility-sensitive MRI, while its attenuation or loss in PD supports cautious adjunctive diagnostic use.\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:bold>Critical Relevance Statement<\/jats:bold>\n                      This review critically evaluates the biological basis, MRI interpretation, diagnostic limitations, and evolving multimodal and AI-based assessment of the STS, guiding radiologists toward its standardized and cautious adjunct use in the clinical imaging assessment of parkinsonism.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13244-026-02401-6","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:42:17Z","timestamp":1790754137000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The swallow tail sign: mechanisms, neuroimaging advances and future perspectives"],"prefix":"10.1186","volume":"17","author":[{"given":"Zhixuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoxuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqin","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caohui","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2980-5171","authenticated-orcid":false,"given":"Xin","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"2401_CR1","doi-asserted-by":"crossref","unstructured":"Bloem BR, Okun MS, Klein C (2021) Parkinson\u2019s disease. Lancet 397:2284\u20132303","DOI":"10.1016\/S0140-6736(21)00218-X"},{"key":"2401_CR2","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3233\/JPD-230328","volume":"14","author":"S Maheshwari","year":"2024","unstructured":"Maheshwari S, Akram H, Bulstrode H et al (2024) Dopaminergic cell replacement for Parkinson\u2019s disease: addressing the intracranial delivery hurdle. J Parkinsons Dis 14:415\u2013435","journal-title":"J Parkinsons Dis"},{"key":"2401_CR3","doi-asserted-by":"publisher","first-page":"e080952","DOI":"10.1136\/bmj-2024-080952","volume":"388","author":"D Su","year":"2025","unstructured":"Su D, Cui Y, He C et al (2025) Projections for prevalence of Parkinson\u2019s disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021. BMJ 388:e080952","journal-title":"BMJ"},{"key":"2401_CR4","doi-asserted-by":"crossref","unstructured":"Postuma RB, Berg D, Stern M et al (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30:1591\u20131601","DOI":"10.1002\/mds.26424"},{"key":"2401_CR5","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1007\/s00330-017-4950-5","volume":"28","author":"A Stezin","year":"2018","unstructured":"Stezin A, Naduthota RM, Botta R et al (2018) Clinical utility of visualisation of nigrosome-1 in patients with Parkinson\u2019s disease. Eur Radiol 28:718\u2013726","journal-title":"Eur Radiol"},{"key":"2401_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/mds.27183","volume":"33","author":"W Li","year":"2018","unstructured":"Li W, Lao-Kaim NP, Roussakis AA et al (2018) 11 C-PE2I and 18 F-dopa PET for assessing progression rate in Parkinson\u2019s: a longitudinal study. Mov Disord 33:117\u2013127","journal-title":"Mov Disord"},{"key":"2401_CR7","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/ana.25103","volume":"82","author":"V Kaasinen","year":"2017","unstructured":"Kaasinen V, Vahlberg T (2017) Striatal dopamine in parkinson disease: a meta-analysis of imaging studies. Ann Neurol 82:873\u2013882","journal-title":"Ann Neurol"},{"key":"2401_CR8","doi-asserted-by":"crossref","unstructured":"Meyer PT, Frings L, R\u00fccker G, Hellwig S (2017) 18F-FDG PET in Parkinsonism: differential diagnosis and evaluation of cognitive impairment. J Nucl Med 58:1888\u20131898","DOI":"10.2967\/jnumed.116.186403"},{"key":"2401_CR9","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1007\/s00259-018-4031-2","volume":"45","author":"Z Walker","year":"2018","unstructured":"Walker Z, Gandolfo F, Orini S et al (2018) Clinical utility of FDG PET in Parkinson\u2019s disease and atypical parkinsonism associated with dementia. Eur J Nucl Med Mol Imaging 45:1534\u20131545","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2401_CR10","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1002\/mds.29186","volume":"37","author":"K Matsuoka","year":"2022","unstructured":"Matsuoka K, Ono M, Takado Y et al (2022) High-contrast imaging of \u03b1-synuclein pathologies in living patients with multiple system atrophy. Mov Disord 37:2159\u20132161","journal-title":"Mov Disord"},{"key":"2401_CR11","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1016\/j.cell.2023.06.004","volume":"186","author":"J Xiang","year":"2023","unstructured":"Xiang J, Tao Y, Xia Y et al (2023) Development of an \u03b1-synuclein positron emission tomography tracer for imaging synucleinopathies. Cell 186:3350\u20133367.e19","journal-title":"Cell"},{"key":"2401_CR12","doi-asserted-by":"publisher","first-page":"e242044","DOI":"10.1148\/radiol.242044","volume":"317","author":"S Haller","year":"2025","unstructured":"Haller S, He N, Schwarz S, Haacke EM (2025) Clinical MRI biomarkers to differentiate parkinson disease from its mimics. Radiology 317:e242044","journal-title":"Radiology"},{"key":"2401_CR13","doi-asserted-by":"publisher","first-page":"e93814","DOI":"10.1371\/journal.pone.0093814","volume":"9","author":"ST Schwarz","year":"2014","unstructured":"Schwarz ST, Afzal M, Morgan PS, Bajaj N, Gowland PA, Auer DP (2014) The \u2018swallow tail\u2019 appearance of the healthy nigrosome\u2014a new accurate test of Parkinson\u2019s disease: a case-control and retrospective cross-sectional MRI study at 3T. PLoS One 9:e93814","journal-title":"PLoS One"},{"key":"2401_CR14","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41582-022-00618-9","volume":"18","author":"J-Y Lee","year":"2022","unstructured":"Lee J-Y, Martin-Bastida A, Murueta-Goyena A et al (2022) Multimodal brain and retinal imaging of dopaminergic degeneration in parkinson disease. Nat Rev Neurol 18:203\u2013220","journal-title":"Nat Rev Neurol"},{"key":"2401_CR15","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1093\/brain\/122.8.1421","volume":"122","author":"P Damier","year":"1999","unstructured":"Damier P, Hirsch EC, Agid Y, Graybiel AM (1999) The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry. Brain 122:1421\u20131436","journal-title":"Brain"},{"key":"2401_CR16","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/brain\/122.8.1437","volume":"122","author":"P Damier","year":"1999","unstructured":"Damier P, Hirsch EC, Agid Y, Graybiel AM (1999) The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain 122:1437\u20131448.","journal-title":"Brain"},{"key":"2401_CR17","doi-asserted-by":"publisher","first-page":"20180842","DOI":"10.1259\/bjr.20180842","volume":"92","author":"EY Kim","year":"2019","unstructured":"Kim EY, Sung YH, Lee J (2019) Nigrosome 1 imaging: technical considerations and clinical applications. Br J Radiol 92:20180842","journal-title":"Br J Radiol"},{"key":"2401_CR18","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1002\/mds.26171","volume":"30","author":"E Reiter","year":"2015","unstructured":"Reiter E, Mueller C, Pinter B et al (2015) Dorsolateral nigral hyperintensity on 3.0T susceptibility-weighted imaging in neurodegenerative parkinsonism. Mov Disord 30:1068\u20131076","journal-title":"Mov Disord"},{"key":"2401_CR19","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1148\/radiol.212696","volume":"305","author":"M Brammerloh","year":"2022","unstructured":"Brammerloh M, Kirilina E, Alkemade A et al (2022) Swallow tail sign: revisited. Radiology 305:674\u2013677","journal-title":"Radiology"},{"key":"2401_CR20","doi-asserted-by":"publisher","first-page":"117810","DOI":"10.1016\/j.neuroimage.2021.117810","volume":"230","author":"N He","year":"2021","unstructured":"He N, Ghassaban K, Huang P et al (2021) Imaging iron and neuromelanin simultaneously using a single 3D gradient echo magnetization transfer sequence: combining neuromelanin, iron and the nigrosome-1 sign as complementary imaging biomarkers in early stage Parkinson\u2019s disease. Neuroimage 230:117810","journal-title":"Neuroimage"},{"key":"2401_CR21","doi-asserted-by":"publisher","first-page":"20180037","DOI":"10.1259\/bjr.20180037","volume":"91","author":"H Takahashi","year":"2018","unstructured":"Takahashi H, Watanabe Y, Tanaka H et al (2018) Quantifying changes in nigrosomes using quantitative susceptibility mapping and neuromelanin imaging for the diagnosis of early-stage Parkinson\u2019s disease. Br J Radiol 91:20180037","journal-title":"Br J Radiol"},{"key":"2401_CR22","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ejrad.2018.06.024","volume":"109","author":"H Takahashi","year":"2018","unstructured":"Takahashi H, Watanabe Y, Tanaka H et al (2018) Comprehensive MRI quantification of the substantia nigra pars compacta in Parkinson\u2019s disease. Eur J Radiol 109:48\u201356","journal-title":"Eur J Radiol"},{"key":"2401_CR23","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/jmri.28414","volume":"57","author":"N He","year":"2023","unstructured":"He N, Chen Y, LeWitt PA, Yan F, Haacke EM (2023) Application of neuromelanin MR imaging in Parkinson disease. J Magn Reson Imaging 57:337\u2013352.","journal-title":"J Magn Reson Imaging"},{"key":"2401_CR24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41531-018-0047-3","volume":"4","author":"D Sulzer","year":"2018","unstructured":"Sulzer D, Cassidy C, Horga G et al (2018) Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson\u2019s disease. NPJ Parkinsons Dis 4:11","journal-title":"NPJ Parkinsons Dis"},{"key":"2401_CR25","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/jon.12576","volume":"29","author":"T Kau","year":"2019","unstructured":"Kau T, Hametner S, Endmayr V et al (2019) Microvessels may confound the \u201cSwallow Tail Sign\u201d in normal aged midbrains: a postmortem 7 T SW-MRI study. J Neuroimaging 29:65\u201369","journal-title":"J Neuroimaging"},{"key":"2401_CR26","doi-asserted-by":"crossref","unstructured":"Schmidt MA, Engelhorn T, Marxreiter F et al (2017) Ultra high-field SWI of the substantia nigra at 7T: reliability and consistency of the swallow-tail sign. BMC Neurol 17:194","DOI":"10.1186\/s12883-017-0975-2"},{"key":"2401_CR27","doi-asserted-by":"crossref","unstructured":"Blazejewska AI, Schwarz ST, Pitiot A et al (2013) Visualization of nigrosome 1 and its loss in PD: pathoanatomical correlation and in vivo 7 T MRI. Neurology 81:534\u2013540","DOI":"10.1212\/WNL.0b013e31829e6fd2"},{"key":"2401_CR28","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/jnc.13648","volume":"138","author":"A Biesemeier","year":"2016","unstructured":"Biesemeier A, Eibl O, Eswara S et al (2016) Elemental mapping of neuromelanin organelles of human substantia nigra: correlative ultrastructural and chemical analysis by analytical transmission electron microscopy and nano-secondary ion mass spectrometry. J Neurochem 138:339\u2013353","journal-title":"J Neurochem"},{"key":"2401_CR29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1148\/radiol.2021203071","volume":"299","author":"S Haller","year":"2021","unstructured":"Haller S, Haacke EM, Thurnher MM, Barkhof F (2021) Susceptibility-weighted imaging: technical essentials and clinical neurologic applications. Radiology 299:3\u201326","journal-title":"Radiology"},{"key":"2401_CR30","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/jon.12841","volume":"31","author":"H Sotoudeh","year":"2021","unstructured":"Sotoudeh H, Sarrami AH, Wang JX et al (2021) Susceptibility-weighted imaging in neurodegenerative disorders: a review. J Neuroimaging 31:459\u2013470","journal-title":"J Neuroimaging"},{"key":"2401_CR31","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41531-025-00972-7","volume":"11","author":"CF Madelung","year":"2025","unstructured":"Madelung CF, L\u00f8kkegaard A, Fuglsang SA et al (2025) High-resolution mapping of substantia nigra in Parkinson\u2019s disease using 7 tesla magnetic resonance imaging. NPJ Parkinsons Dis 11:113","journal-title":"NPJ Parkinsons Dis"},{"key":"2401_CR32","doi-asserted-by":"crossref","unstructured":"Gorell JM, Ordidge RJ, Brown GG et al (1995) Increased iron-related MRI contrast in the substantia nigra in Parkinson\u2019s disease. Neurology 45:1138\u20131143","DOI":"10.1212\/WNL.45.6.1138"},{"key":"2401_CR33","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.2214\/AJR.16.16092","volume":"207","author":"SW Oh","year":"2016","unstructured":"Oh SW, Shin NY, Lee JJ et al (2016) Correlation of 3D FLAIR and dopamine transporter imaging in patients with parkinsonism. AJR Am J Roentgenol 207:1089\u20131094","journal-title":"AJR Am J Roentgenol"},{"key":"2401_CR34","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3390\/tomography7020010","volume":"7","author":"T-W Lee","year":"2021","unstructured":"Lee T-W, Chen CY, Chen K et al (2021) Evaluation of the swallow-tail sign and correlations of neuromelanin signal with susceptibility and relaxations. Tomography 7:107\u2013119","journal-title":"Tomography"},{"key":"2401_CR35","doi-asserted-by":"crossref","unstructured":"Meijer FJ, Steens SC, van Rumund A et al (2016) Nigrosome-1 on susceptibility weighted imaging to differentiate Parkinson\u2019s disease from atypical parkinsonism: an in vivo and ex vivo pilot study. Pol J Radiol 81:363\u2013369","DOI":"10.12659\/PJR.897090"},{"key":"2401_CR36","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.3174\/ajnr.A5274","volume":"38","author":"S Shams","year":"2017","unstructured":"Shams S, F\u00e4llmar D, Schwarz S et al (2017) MRI of the swallow tail sign: A useful marker in the diagnosis of Lewy body dementia? AJNR Am J Neuroradiol 38:1737\u20131741","journal-title":"AJNR Am J Neuroradiol"},{"key":"2401_CR37","doi-asserted-by":"publisher","first-page":"e240680","DOI":"10.1148\/radiol.240680","volume":"316","author":"Y Xing","year":"2025","unstructured":"Xing Y, Naidu S, Mart\u00edn-Bastida A et al (2025) Diagnostic value of swallow tail sign at brain MRI in patients with clinically uncertain parkinsonian syndrome. Radiology 316:e240680","journal-title":"Radiology"},{"key":"2401_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-021-00758-x","volume":"11","author":"E Michler","year":"2021","unstructured":"Michler E, Kaiser D, Eleftheriadou K, Falkenburger B, Kotzerke J, Hober\u00fcck S (2021) Comparison of 6-[(18)F]FDOPA PET with Nigrosome 1 detection in patients with parkinsonism. EJNMMI Res 11:16","journal-title":"EJNMMI Res"},{"key":"2401_CR39","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/mdc3.14304","volume":"12","author":"VS Tseriotis","year":"2025","unstructured":"Tseriotis VS, Eleftheriadou K, Mavridis T, Konstantis G, Falkenburger B, Arnaoutoglou M (2025) Is the swallow tail sign a useful imaging biomarker in clinical neurology? A systematic review. Mov Disord Clin Pr 12:134\u2013147","journal-title":"Mov Disord Clin Pr"},{"key":"2401_CR40","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/mds.26932","volume":"32","author":"P Mahlknecht","year":"2017","unstructured":"Mahlknecht P, Krismer F, Poewe W, Seppi K (2017) Meta-analysis of dorsolateral nigral hyperintensity on magnetic resonance imaging as a marker for Parkinson\u2019s disease. Mov Disord 32:619\u2013623","journal-title":"Mov Disord"},{"key":"2401_CR41","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/acn3.50962","volume":"7","author":"TR Barber","year":"2020","unstructured":"Barber TR, Griffanti L, Bradley KM et al (2020) Nigrosome 1 imaging in REM sleep behavior disorder and its association with dopaminergic decline. Ann Clin Transl Neurol 7:26\u201335","journal-title":"Ann Clin Transl Neurol"},{"key":"2401_CR42","doi-asserted-by":"crossref","unstructured":"Zhang X, Chai C, Ghassaban K et al (2021) Assessing brain iron and volume of subcortical nuclei in idiopathic rapid eye movement sleep behavior disorder. Sleep 44:zsab131","DOI":"10.1093\/sleep\/zsab131"},{"key":"2401_CR43","doi-asserted-by":"publisher","first-page":"e02202","DOI":"10.1002\/brb3.2202","volume":"11","author":"J Prasuhn","year":"2021","unstructured":"Prasuhn J, Neumann A, Strautz R et al (2021) Clinical MR imaging in Parkinson\u2019s disease: How useful is the swallow tail sign? Brain Behav 11:e02202","journal-title":"Brain Behav"},{"key":"2401_CR44","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.nicl.2018.05.027","volume":"19","author":"ST Schwarz","year":"2018","unstructured":"Schwarz ST, Mougin O, Xing Y et al (2018) Parkinson\u2019s disease related signal change in the nigrosomes 1\u20135 and the substantia nigra using T2* weighted 7T MRI. Neuroimage Clin 19:683\u2013689","journal-title":"Neuroimage Clin"},{"key":"2401_CR45","doi-asserted-by":"publisher","first-page":"117581","DOI":"10.1016\/j.jns.2021.117581","volume":"428","author":"DS Kim","year":"2021","unstructured":"Kim DS, Tung GA, Akbar U, Friedman JH (2021) The evaluation of the swallow tail sign in patients with parkinsonism and gait disorders. J Neurol Sci 428:117581","journal-title":"J Neurol Sci"},{"key":"2401_CR46","doi-asserted-by":"crossref","unstructured":"Bae YJ, Kim JM, Kim E et al (2016) Loss of nigral hyperintensity on 3 Tesla MRI of Parkinsonism: comparison with (123) I-FP-CIT SPECT. Mov Disord 31:684\u2013692","DOI":"10.1002\/mds.26584"},{"key":"2401_CR47","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.clinimag.2017.04.005","volume":"44","author":"CS Oustwani","year":"2017","unstructured":"Oustwani CS, Korutz AW, Lester MS, Kianirad Y, Simuni T, Hijaz TA (2017) Can loss of the swallow tail sign help distinguish between Parkinson Disease and the Parkinson-Plus syndromes? Clin Imaging 44:66\u201369","journal-title":"Clin Imaging"},{"key":"2401_CR48","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00702-016-1529-2","volume":"123","author":"D Frosini","year":"2016","unstructured":"Frosini D, Ceravolo R, Tosetti M, Bonuccelli U, Cosottini M (2016) Nigral involvement in atypical parkinsonisms: evidence from a pilot study with ultra-high field MRI. J Neural Transm (Vienna) 123:509\u2013513","journal-title":"J Neural Transm (Vienna)"},{"key":"2401_CR49","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1002\/mds.27038","volume":"32","author":"JL Whitwell","year":"2017","unstructured":"Whitwell JL, H\u00f6glinger GU, Antonini A et al (2017) Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be? Mov Disord 32:955\u2013971","journal-title":"Mov Disord"},{"key":"2401_CR50","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3233\/JAD-180687","volume":"67","author":"G Rizzo","year":"2019","unstructured":"Rizzo G, De Blasi R, Capozzo R et al (2019) Loss of swallow tail sign on susceptibility-weighted imaging in dementia with Lewy bodies. J Alzheimers Dis 67:61\u201365","journal-title":"J Alzheimers Dis"},{"key":"2401_CR51","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.1007\/s00415-024-12381-6","volume":"271","author":"VS Tseriotis","year":"2024","unstructured":"Tseriotis VS, Mavridis T, Eleftheriadou K et al (2024) Loss of the \u201cswallow tail sign\u201d on susceptibility-weighted imaging in the diagnosis of dementia with Lewy bodies: a systematic review and meta-analysis. J Neurol 271:3754\u20133763","journal-title":"J Neurol"},{"key":"2401_CR52","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1177\/1877718X251387027","volume":"16","author":"L Falcitano","year":"2026","unstructured":"Falcitano L, Calizzano F, Mattioli P et al (2026) MRI susceptibility map weighted imaging (SMWI) as a neurodegeneration biomarker in the prodromal to overt alpha-synucleinopathy continuum. J Parkinsons Dis 16:61\u201371","journal-title":"J Parkinsons Dis"},{"key":"2401_CR53","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1111\/jon.12775","volume":"30","author":"CE Weber","year":"2020","unstructured":"Weber CE, Ebert A, Platten M, Gass A, Eisele P (2020) Susceptibility-weighted 3T MRI of the swallow tail sign in multiple sclerosis: a case control study. J Neuroimaging 30:766\u2013768","journal-title":"J Neuroimaging"},{"key":"2401_CR54","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1007\/s13760-022-02107-8","volume":"123","author":"XL Cui","year":"2023","unstructured":"Cui XL, Liu S, Zhang YM, Zhao HD, Shi JQ (2023) Loss of swallow tail sign on susceptibility-weighted imaging in neurosyphilis mimicking Alzheimer\u2019s disease: a case report. Acta Neurol Belg 123:1581\u20131583","journal-title":"Acta Neurol Belg"},{"key":"2401_CR55","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.3174\/ajnr.A4412","volume":"36","author":"Y Noh","year":"2015","unstructured":"Noh Y, Sung YH, Lee J, Kim EY (2015) Nigrosome 1 detection at 3T MRI for the diagnosis of early-stage idiopathic parkinson disease: assessment of diagnostic accuracy and agreement on imaging asymmetry and clinical laterality. AJNR Am J Neuroradiol 36:2010\u20132016","journal-title":"AJNR Am J Neuroradiol"},{"key":"2401_CR56","first-page":"30","volume":"96","author":"WF Sui","year":"2016","unstructured":"Sui WF, Zhang HY, Xu J, Xu Y, Wu JT (2016) Application of swallow tail appearance in patients with Parkinson\u2019s disease. Zhonghua Yi Xue Za Zhi 96:30\u201332","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"2401_CR57","doi-asserted-by":"publisher","first-page":"111030","DOI":"10.1016\/j.ejrad.2023.111030","volume":"167","author":"M Chen","year":"2023","unstructured":"Chen M, Wang Y, Zhang C et al (2023) Free water and iron content in the substantia nigra at different stages of Parkinson\u2019s disease. Eur J Radiol 167:111030","journal-title":"Eur J Radiol"},{"key":"2401_CR58","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1002\/jmri.24413","volume":"40","author":"S Liu","year":"2014","unstructured":"Liu S, Mok K, Neelavalli J et al (2014) Improved MR venography using quantitative susceptibility-weighted imaging. J Magn Reson Imaging 40:698\u2013708","journal-title":"J Magn Reson Imaging"},{"key":"2401_CR59","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/jmri.25553","volume":"46","author":"Y Nam","year":"2017","unstructured":"Nam Y, Gho SM, Kim DH, Kim EY, Lee J (2017) Imaging of nigrosome 1 in substantia nigra at 3T using multiecho susceptibility map-weighted imaging (SMWI). J Magn Reson Imaging 46:528\u2013536","journal-title":"J Magn Reson Imaging"},{"key":"2401_CR60","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/mds.27929","volume":"35","author":"J Sun","year":"2020","unstructured":"Sun J, Lai Z, Ma J et al (2020) Quantitative evaluation of iron content in idiopathic rapid eye movement sleep behavior disorder. Mov Disord 35:478\u2013485","journal-title":"Mov Disord"},{"key":"2401_CR61","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/jmri.27386","volume":"53","author":"N Wang","year":"2021","unstructured":"Wang N, Liu XL, Li L et al (2021) Screening for early-stage Parkinson\u2019s disease: swallow tail sign on MRI susceptibility map-weighted images compared with PET. J Magn Reson Imaging 53:722\u2013730","journal-title":"J Magn Reson Imaging"},{"key":"2401_CR62","doi-asserted-by":"publisher","first-page":"102103","DOI":"10.1016\/j.nicl.2019.102103","volume":"25","author":"Z Cheng","year":"2020","unstructured":"Cheng Z, He N, Huang P et al (2020) Imaging the nigrosome 1 in the substantia nigra using susceptibility weighted imaging and quantitative susceptibility mapping: an application to Parkinson\u2019s disease. Neuroimage Clin 25:102103","journal-title":"Neuroimage Clin"},{"key":"2401_CR63","doi-asserted-by":"publisher","first-page":"102903","DOI":"10.1016\/j.radi.2025.102903","volume":"31","author":"MR Hamed","year":"2025","unstructured":"Hamed MR, Kenawy MA, Mohamed S, El-Samahy M, Ereiba KT, Eissa A (2025) Fast susceptibility-weighted imaging using echo planar imaging at 1.5 T for swallow tail sign biomarker detection in Parkinson\u2019s disease. Radiography (Lond) 31:102903","journal-title":"Radiography (Lond)"},{"key":"2401_CR64","doi-asserted-by":"crossref","unstructured":"Cassidy CM, Zucca FA, Girgis RR et al (2019) Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain. Proc Natl Acad Sci USA 116:5108\u20135117","DOI":"10.1073\/pnas.1807983116"},{"key":"2401_CR65","doi-asserted-by":"crossref","unstructured":"Schwarz ST, Xing Y, Tomar P, Bajaj N, Auer DP (2017) In vivo assessment of brainstem depigmentation in parkinson disease: potential as a severity marker for multicenter studies. Radiology 283:789\u2013798","DOI":"10.1148\/radiol.2016160662"},{"key":"2401_CR66","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3233\/JPD-171135","volume":"7","author":"M Fabbri","year":"2017","unstructured":"Fabbri M, Reim\u00e3o S, Carvalho M et al (2017) Substantia nigra neuromelanin as an imaging biomarker of disease progression in Parkinson\u2019s disease. J Parkinsons Dis 7:491\u2013501","journal-title":"J Parkinsons Dis"},{"key":"2401_CR67","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1007\/s00330-020-07240-7","volume":"31","author":"SJ Cho","year":"2021","unstructured":"Cho SJ, Bae YJ, Kim JM et al (2021) Diagnostic performance of neuromelanin-sensitive magnetic resonance imaging for patients with Parkinson\u2019s disease and factor analysis for its heterogeneity: a systematic review and meta-analysis. Eur Radiol 31:1268\u20131280","journal-title":"Eur Radiol"},{"key":"2401_CR68","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1148\/radiol.14131448","volume":"271","author":"M Cosottini","year":"2014","unstructured":"Cosottini M, Frosini D, Pesaresi I et al (2014) MR imaging of the substantia nigra at 7 T enables diagnosis of Parkinson disease. Radiology 271:831\u2013838","journal-title":"Radiology"},{"key":"2401_CR69","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s00415-025-13035-x","volume":"272","author":"X Wang","year":"2025","unstructured":"Wang X, Xiong Y, Duan C et al (2025) The disease-specific structural pattern in Parkinson\u2019s disease and its cortical characteristics associated with gene function: a 7-tesla MRI study. J Neurol 272:300","journal-title":"J Neurol"},{"key":"2401_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41597-025-05325-w","volume":"12","author":"M Lancione","year":"2025","unstructured":"Lancione M, Donatelli G, Migaleddu G et al (2025) High resolution multi-parametric probabilistic in vivo atlas of dorsolateral nigral hyperintensity via 7 T MRI. Sci Data 12:958","journal-title":"Sci Data"},{"key":"2401_CR71","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3174\/ajnr.A4158","volume":"36","author":"M Cosottini","year":"2015","unstructured":"Cosottini M, Frosini D, Pesaresi I et al (2015) Comparison of 3T and 7T susceptibility-weighted angiography of the substantia nigra in diagnosing parkinson disease. AJNR Am J Neuroradiol 36:461\u2013466","journal-title":"AJNR Am J Neuroradiol"},{"key":"2401_CR72","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.parkreldis.2017.08.002","volume":"43","author":"D Frosini","year":"2017","unstructured":"Frosini D, Cosottini M, Donatelli G et al (2017) Seven tesla MRI of the substantia nigra in patients with rapid eye movement sleep behavior disorder. Parkinsonism Relat Disord 43:105\u2013109","journal-title":"Parkinsonism Relat Disord"},{"key":"2401_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-025-00495-4","volume":"14","author":"D Su","year":"2025","unstructured":"Su D, Zhang Z, Zhang Z et al (2025) Dorsal hyperintensity and iron deposition patterns in the substantia nigra of Parkinson\u2019s disease, idiopathic REM sleep behavior disorder, and parkinson-plus syndromes at 7T MRI: a prospective diagnostic study. Transl Neurodegener 14:35","journal-title":"Transl Neurodegener"},{"key":"2401_CR74","doi-asserted-by":"publisher","first-page":"623","DOI":"10.21037\/qims-24-1498","volume":"15","author":"X Wang","year":"2025","unstructured":"Wang X, Xiong Y, Hu J et al (2025) Thalamic functional connectivity on 7-tesla magnetic resonance imaging and its relation to motor signs in early-stage Parkinson\u2019s disease. Quant Imaging Med Surg 15:623\u2013635","journal-title":"Quant Imaging Med Surg"},{"key":"2401_CR75","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.nicl.2016.11.015","volume":"13","author":"LA Massey","year":"2017","unstructured":"Massey LA, Miranda MA, Al-Helli O et al (2017) 9.4 T MR microscopy of the substantia nigra with pathological validation in controls and disease. Neuroimage Clin 13:154\u2013163","journal-title":"Neuroimage Clin"},{"key":"2401_CR76","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/mp.13999","volume":"47","author":"M Jo","year":"2020","unstructured":"Jo M, Oh SH (2020) A preliminary attempt to visualize nigrosome 1 in the substantia nigra for Parkinson\u2019s disease at 3T: an efficient susceptibility map-weighted imaging (SMWI) with quantitative susceptibility mapping using deep neural network (QSMnet). Med Phys 47:1151\u20131160","journal-title":"Med Phys"},{"key":"2401_CR77","first-page":"1904","volume":"60","author":"C Wang","year":"2024","unstructured":"Wang C, He N, Zhang Y et al (2024) Enhancing nigrosome-1 sign identification via interpretable AI using true susceptibility weighted imaging. J Magn Reson Imaging 60:1904\u20131915","journal-title":"J Magn Reson Imaging"},{"key":"2401_CR78","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/jmri.29073","volume":"60","author":"M Ariz","year":"2024","unstructured":"Ariz M, Mart\u00ednez M, Alvarez I et al (2024) Automatic segmentation and quantification of Nigrosome-1 neuromelanin and iron in MRI: a candidate biomarker for Parkinson\u2019s disease. J Magn Reson Imaging 60:534\u2013547","journal-title":"J Magn Reson Imaging"},{"key":"2401_CR79","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3389\/fnagi.2019.00167","volume":"11","author":"Z Cheng","year":"2019","unstructured":"Cheng Z, Zhang J, He N et al (2019) Radiomic features of the Nigrosome-1 region of the substantia nigra: using quantitative susceptibility mapping to assist the diagnosis of idiopathic Parkinson\u2019s disease. Front Aging Neurosci 11:167","journal-title":"Front Aging Neurosci"},{"key":"2401_CR80","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.parkreldis.2020.07.002","volume":"78","author":"MT Chau","year":"2020","unstructured":"Chau MT, Todd G, Wilcox R, Agzarian M, Bezak E (2020) Diagnostic accuracy of the appearance of Nigrosome-1 on magnetic resonance imaging in Parkinson\u2019s disease: a systematic review and meta-analysis. Parkinsonism Relat Disord 78:12\u201320","journal-title":"Parkinsonism Relat Disord"},{"key":"2401_CR81","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s11604-025-01858-7","volume":"44","author":"Y Fushimi","year":"2026","unstructured":"Fushimi Y, Ghassaban K, Sethi SK et al (2026) Integrated evaluation of Nigrosome 1 sign, neuromelanin-sensitive MR and iron deposition. Jpn J Radio 44:24\u201334","journal-title":"Jpn J Radio"},{"key":"2401_CR82","doi-asserted-by":"publisher","first-page":"119814","DOI":"10.1016\/j.neuroimage.2022.119814","volume":"266","author":"M Jokar","year":"2023","unstructured":"Jokar M, Jin Z, Huang P et al (2023) Diagnosing Parkinson\u2019s disease by combining neuromelanin and iron imaging features using an automated midbrain template approach. Neuroimage 266:119814","journal-title":"Neuroimage"},{"key":"2401_CR83","doi-asserted-by":"publisher","first-page":"6503","DOI":"10.21037\/qims-23-87","volume":"13","author":"Q Cao","year":"2023","unstructured":"Cao Q, Han X, Tang D et al (2023) Diagnostic value of combined magnetic resonance imaging techniques in the evaluation of Parkinson disease. Quant Imaging Med Surg 13:6503\u20136516","journal-title":"Quant Imaging Med Surg"},{"key":"2401_CR84","doi-asserted-by":"crossref","unstructured":"Jin L, Wang J, Wang C et al (2019) Combined visualization of nigrosome-1 and neuromelanin in the substantia nigra using 3T MRI for the differential diagnosis of essential tremor and de novo Parkinson\u2019s disease. Front Neurol 10:100","DOI":"10.3389\/fneur.2019.00100"},{"key":"2401_CR85","doi-asserted-by":"publisher","first-page":"3174","DOI":"10.1007\/s00330-017-4743-x","volume":"27","author":"N Wang","year":"2017","unstructured":"Wang N, Yang H, Li C, Fan G, Luo X (2017) Using \u2018swallow-tail\u2019 sign and putaminal hypointensity as biomarkers to distinguish multiple system atrophy from idiopathic Parkinson\u2019s disease: a susceptibility-weighted imaging study. Eur Radiol 27:3174\u20133180","journal-title":"Eur Radiol"},{"key":"2401_CR86","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41531-025-01043-7","volume":"11","author":"L Dong","year":"2025","unstructured":"Dong L, Zhou W, An R et al (2025) Paramagnetic susceptibility mapping better quantifies brain iron content in Parkinson\u2019s disease with RBD. NPJ Parkinsons Dis 11:192","journal-title":"NPJ Parkinsons Dis"},{"key":"2401_CR87","doi-asserted-by":"publisher","first-page":"120148","DOI":"10.1016\/j.neuroimage.2023.120148","volume":"274","author":"Z Li","year":"2023","unstructured":"Li Z, Feng R, Liu Q et al (2023) APART-QSM: an improved sub-voxel quantitative susceptibility mapping for susceptibility source separation using an iterative data fitting method. NeuroImage 274:120148","journal-title":"NeuroImage"},{"key":"2401_CR88","doi-asserted-by":"publisher","first-page":"121060","DOI":"10.1016\/j.neuroimage.2025.121060","volume":"308","author":"J Kim","year":"2025","unstructured":"Kim J, Kim M, Ji S et al (2025) In-vivo high-resolution \u03c7-separation at 7T. NeuroImage 308:121060","journal-title":"NeuroImage"}],"container-title":["Insights into Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-026-02401-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13244-026-02401-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-026-02401-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:03:43Z","timestamp":1790759023000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13244-026-02401-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":88,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2401"],"URL":"https:\/\/doi.org\/10.1186\/s13244-026-02401-6","relation":{},"ISSN":["1869-4101"],"issn-type":[{"value":"1869-4101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"assertion":[{"value":"6 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Consent to publish has been obtained from the relevant individual(s) as applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"240"}}